E2F1 and ovarian carcinoma: We found that E2F1 plasmid and RhoC siRNA co-transfection greatly reversed the oncogenic role of E2F1 in ovarian carcinoma cell phenotype, revealing that RhoC plays a central role in the oncogenic regulation of E2F1/miR-519d on ovarian carcinogenesis and development.